Probiotic <i>Limosilactobacillus reuteri</i> DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

Probiotic <i>Limosilactobacillus reuteri</i> DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

The probiotic <i>Limosilactobacillus reuteri</i> DSM 17938 produces anti-inflammatory effects in scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (called IPEX syndrome in humans), caused by regulatory T cell (Treg)...

Full description

Bibliographic Details
Main Authors: Erini Nessim Kostandy, Ji Ho Suh, Xiangjun Tian, Beanna Okeugo, Erin Rubin, Sara Shirai, Meng Luo, Christopher M. Taylor, Kang Ho Kim, J. Marc Rhoads, Yuying Liu
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Nutrients
Subjects:
probiotics
regulatory T cell
autoimmunity
lipid metabolism
microbiota
inflammation
Online Access:https://www.mdpi.com/2072-6643/16/4/511

Internet

https://www.mdpi.com/2072-6643/16/4/511

Similar Items